Home›People›Alexander Khoruts
Alexander Khoruts

Alexander Khoruts

Chief medical officer at Gut-Brain-Axis Therapeutics

Director
Updated Nov 4, 2026·Latest SEC filing Oct 27, 2026·Suggest an edit

About Alexander Khoruts

Alexander Khoruts is chief medical officer of Gut-Brain-Axis Therapeutics, which is developing a gut bacteria transplant for autism and Pitt-Hopkins syndrome. He is also one of its directors. He is a professor of medicine at the University of Minnesota and a Distinguished McKnight Professor. He directs the university's Microbiota Therapeutics Program, which makes treatments from donor gut bacteria for clinical trials with academic partners.

He is a gastroenterologist who treats patients with complex Clostridioides difficile infections. He holds an MD from the University of Minnesota.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Alexander Khoruts in the role, so the role may have started earlier or lasted longer.

Gut-Brain-Axis Therapeutics Inc. Current
Chief Medical Officer and director
2025 – Present · Tempe, AZ
Develops a treatment that replaces harmful gut bacteria with healthy donor bacteria, aimed at autism and Pitt-Hopkins syndrome.
University of Minnesota Current
Director, Microbiota Therapeutics Program
Professor of Medicine, Division of Gastroenterology, Hepatology and Nutrition
Distinguished McKnight Professor (2025 – Present)
2025 – Present

Key Colleagues at Startups

The people Alexander Khoruts works with at each company, as listed on that company's latest Form D.

Gut-Brain-Axis Therapeutics Inc. · Form D/A, Oct 27, 2026
James Adams
James Adams
President and Chief Executive Officer, director
Rosa Krajmalnik-Brown
Rosa Krajmalnik-Brown
Chief Science Officer and director
Michael Sadowsky
Michael Sadowsky
Chief Manufacturing and Operations Officer, director

Alexander Khoruts in the News

Sources

  1. SECGut-Brain-Axis Therapeutics Inc. Form D/A, filed Oct 27, 2026
  2. University siteStaff & Faculty, University of Minnesota Microbiota Therapeutics Program